CN: 32-1845/R
ISSN: 2095-6975
Cite this paper:
0
HUANG Shao-Peng, GUAN Xin, KAI Guo-Yin, XU Ya-Zhou, XU Yuan, WANG Hao-Jie, PANG Tao, ZHANG Lu-Yong, LIU Ying. Broussonin E suppresses LPS-induced inflammatory response in macrophages via inhibiting MAPK pathway and enhancing JAK2-STAT3 pathway[J]. Chinese Journal of Natural Medicines, 2019, 17(5): 372-380

Broussonin E suppresses LPS-induced inflammatory response in macrophages via inhibiting MAPK pathway and enhancing JAK2-STAT3 pathway

HUANG Shao-Peng1, GUAN Xin2,3, KAI Guo-Yin2, XU Ya-Zhou3, XU Yuan4, WANG Hao-Jie3, PANG Tao3, ZHANG Lu-Yong1,3, LIU Ying1
1 School of Basic Medicine, Center for Drug Screening and Pharmacodynamics Evaluation, School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, China;
2 College of Pharmaceutical Science, Zhejiang Chinese Medical University, Hangzhou 311402, China;
3 Jiangsu Key Laboratory of Drug Screening, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nan-jing 210009, China;
4 School of Medicine and Life Sciences, Nanjing University of Chinese Medicine, Nanjing 210023, China
Abstract:
Macrophages play an important role in inflammation, and excessive and chronic activation of macrophages leads to systemic inflammatory diseases, such as atherosclerosis and rheumatoid arthritis. In this paper, we explored the anti-inflammatory effect of broussonin E, a novel phenolic compound isolated from the barks of Broussonetia kanzinoki, and its underlying molecular mechanisms. We discovered that Broussonin E could suppress the LPS-induced pro-inflammatory production in RAW264.7 cells, involving TNF-α, IL-1β, IL-6, COX-2 and iNOS. And broussonin E enhanced the expressions of anti-inflammatory mediators such as IL-10, CD206 and arginase-1 (Arg-1) in LPS-stimulated RAW264.7 cells. Further, we demonstrated that broussonin E inhibited the LPS-stimulated phosphorylation of ERK and p38 MAPK. Moreover, we found that broussonin E could activate janus kinase (JAK) 2, signal transducer and activator of transcription (STAT) 3. Downregulated pro-inflammatory cytokines and upregulated anti-inflam-matory factors by broussonin E were abolished by using the inhibitor of JAK2-STAT3 pathway, WP1066. Taken together, our results showed that broussonin E could suppress inflammation by modulating macrophages activation state via inhibiting the ERK and p38 MAPK and enhancing JAK2-STAT3 signaling pathway, and can be further developed as a promising drug for the treatment of inflammation-related diseases such as atherosclerosis.
Key words:    Broussonin E    Macrophage polarization    Inflammation    Janus kinase 2    Signal transducer and activator of transcription 3   
Received: 2019-03-24   Revised:
Tools
PDF (1019 KB) Free
Print this page
Email this article to others
Authors
Articles by HUANG Shao-Peng
Articles by GUAN Xin
Articles by KAI Guo-Yin
Articles by XU Ya-Zhou
Articles by XU Yuan
Articles by WANG Hao-Jie
Articles by PANG Tao
Articles by ZHANG Lu-Yong
Articles by LIU Ying
References:
[1] Park SB, Park GH, Kim HN, et al. Anti-inflammatory effect of the extracts from the branch of Taxillus yadoriki being parasitic in Neolitsea sericea in LPS-stimulated RAW264.7 cells[J]. Biomed Pharmacother, 2018, 104:1-7.
[2] Du C, Bhatia M, Tang SC, et al. Mediators of inflammation:Inflammation in cancer, chronic diseases, and wound healing[J]. Mediators Inflamm, 2015, 2015:570653.
[3] Breithaupt H. The new antibiotics[J]. Nat Biotechnol, 1999, 17(12):1165-1169.
[4] Sun Y, Shang D. Inhibitory effects of antimicrobial peptides on lipopolysaccharide-induced inflammation[J]. Mediators Inflamm, 2015, 2015:167572.
[5] Jin X, Han J, Yang S, et al. 11-O-Acetylcyathatriol inhibits MAPK/p38-mediated inflammation in LPS-activated RAW 264.7 macrophages and has a protective effect on ethanol-induced gastric injury[J]. Mol Med Rep, 2016, 14(1):874-880.
[6] Parisi L, Gini E, Baci D, et al. Macrophage polarization in chronic inflammatory diseases:Killers or builders?[J]. J Immunol Res, 2018, 14:8917804.
[7] Chistiakov DA, Myasoedova VA, Revin VV, et al. The impact of interferon-regulatory factors to macrophage differentiation and polarization into M1 and M2[J]. Immunobiology, 2018, 223(1):101-111.
[8] Koh YC, Yang G, Lai CS, et al. Chemopreventive effects of phytochemicals and medicines on M1/M2 polarized macrophage role in inflammation-related diseases[J]. Int J Mol Sci, 2018, 19(8):2208.
[9] Zhang X, Xu F, Liu L, et al. (+)-Borneol improves the efficacy of edaravone against DSS-induced colitis by promoting M2 macrophages polarization via JAK2-STAT3 signaling pathway[J]. Int Immunopharmacol, 2017, 53:1-10.
[10] Abdolmaleki F, Gheibi Hayat SM, Bianconi V, et al. Atherosclerosis and immunity:A perspective[J]. Trends Cardiovasc Med, 2018. DOI:10.1016/j.tcm.2018.09.017
[11] Sica A, Bronte V. Altered macrophage differentiation and immune dysfunction in tumor development[J]. J Clin Invest, 2007, 117(5):1155-1166.
[12] Verreck FA, de Boer T, Langenberg DM, et al. Human IL-23- producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco) bacteria[J]. Proc Natl Acad Sci, 2004, 101(13):4560-4565.
[13] Labonte AC, Tosello-Trampont AC, Hahn YS. The role of macrophage polarization in infectious and inflammatory diseases[J]. Mol Cells, 2014, 37(4):275-285.
[14] Eichenfield DZ, Troutman TD, Link VM, et al. Tissue damage drives co-localization of NF-κB, Smad3, and Nrf2 to direct Rev-erb sensitive wound repair in mouse macrophages[J]. Elife, 2016, 5:e13024.
[15] Kaminska B. MAPK signalling pathways as molecular targets for anti-inflammatory therapy——from molecular mechanisms to therapeutic benefits[J]. Biochim Biophys Acta, 2005, 1754(1-2):253-262.
[16] Yong HY, Koh MS, Moon A. The p38 MAPK inhibitors for the treatment of inflammatory diseases and cancer[J]. Expert Opin Investig Drugs, 2009, 18(12):1893-1905.
[17] Cheng Y, Li X, Tse HF, et al. Gallic acid-L-leucine conjugate protects mice against LPS-induced inflammation and sepsis via correcting proinflammatory lipid mediator profiles and oxidative stress[J]. Oxid Med Cell Longev, 2018, 2018:1081287.
[18] Yang Y, Kim SC, Yu T, et al. Functional roles of p38 mito-gen-activated protein kinase in macrophage-mediated inflammatory responses[J]. Mediators Inflamm, 2014, 2014:352371.
[19] Park EJ, Park SY, Joe EH, et al. 15d-PGJ2 and rosiglitazone suppress Janus kinase-STAT inflammatory signaling through induction of suppressor of cytokine signaling 1(SOCS1) and SOCS3 in glia[J]. J Biol Chem, 2003, 278(17):14747-14752.
[20] Okugawa S, Ota Y, Kitazawa T, et al. Janus kinase 2 is involved in lipopolysaccharide-induced activation of macrophages[J]. Am J Physiol Cell Physiol, 2003, 285(2):C399-408.
[21] Choi JW, Kwon MJ, Kim IH, et al. Pyropia yezoensis glycoprotein promotes the M1 to M2 macrophage phenotypic switch via the STAT3 and STAT6 transcription factors[J]. Int J Mol Med, 2016, 38(2):666-674.
[22] Matsukawa A, Kudo S, Maeda T, et al. Stat3 in resident macrophages as a repressor protein of inflammatory response[J]. J Immunol, 2005, 175(5):3354-3359.
[23] Hollander L, Guo X, Velazquez H, et al. Renalase expression by melanoma and tumor-associated macrophages promotes tumor growth through a STAT3-mediated mechanism[J]. Cancer Res, 2016, 76(13):3884-3894.
[24] Lin N, Yao XG, Li NF. Research advances in suppressor of cytokine signaling 3[J]. Acta Acad Med Sci, 2012, 34(2):178-182.
[25] Wang Y, Ruan W, Mi J, et al. Balasubramide derivative 3C modulates microglia activation via CaMKKβ-dependent AMPK/PGC-1α pathway in neuroinflammatory conditions[J]. Brain Behav Immun, 2018, 67:101-117.
[26] Ruan W, Li J, Xu Y, et al. MALAT1 up-regulator polydatin protects brain microvascular integrity and ameliorates stroke through C/EBPβ/MALAT1/CREB/PGC-1α/PPARγ pathway[J]. Cell Mol Neurobiol, 2019, 39(2):265-286.
[27] Xu Y, Kabba JA, Ruan W, et al. The PGC-1α activator ZLN005 ameliorates ischemia-induced neuronal injury in vitro and in vivo[J]. Cell Mol Neurobiol, 2018, 38(4):929-939.
[28] Woo JH, Lee JH, Kim H, et al. Control of inflammatory responses:a new paradigm for the treatment of chronic neuronal diseases[J]. Exp Neurobiol, 2015, 24(2):95-102.
[29] Atri C, Guerfali FZ, Laouini D. Role of human macrophage polarization in inflammation during infectious diseases[J]. Int J Mol Sci, 2018, 19(6):1801.
[30] Gordon S. Phagocytosis:An immunobiologic process[J]. Immunity, 2016, 44(3):463-475.
[31] Philip S, Tom G, Vasumathi AV. Evaluation of the anti-inflammatory activity of Tinospora cordifolia (Willd.) Miers chloroform extract-a preclinical study[J]. J Pharm Pharmacol, 2018, 70(8):1113-1125.
[32] Yao GD, Sun Q, Song XY, et al. 1, 3-Diphenylpropanes from Daphne giraldii induced apoptosis in hepatocellular carcinoma cells through nuclear factor kappa-B inhibition[J]. Bioorg Chem, 2018, 77:619-624.
[33] Kyriakis JM, Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation[J]. Physiol Rev, 2001, 81(2):807-869.
[34] Pearson G, Robinson F, Beers Gibson T, et al. Mitogen-activated protein (MAP) kinase pathways:regulation and physiological functions[J]. Endocr Rev, 2001, 22(2):153-183.
[35] Herlaar E, Brown Z. p38 MAPK signalling cascades in inflammatory disease[J]. Mol Med Today, 1999, 5(10):439- 447.
[36] Wang Y, Huang Y, Xu Y, et al. A dual AMPK/Nrf2 activator reduces brain inflammation after stroke by enhancing microglia M2 polarization[J]. Antioxid Redox Signal, 2018, 28(2):141-163.
[37] Qi Z, Yin F, Lu L, et al. Baicalein reduces lipopolysaccharide- induced inflammation via suppressing JAK/STATs activation and ROS production[J]. Inflamm Res, 2013, 62(9):845-855.
[38] Zhou Y, Wang J, Yang W, et al. Bergapten prevents lipopolysaccharide-induced inflammation in RAW264.7 cells through suppressing JAK/STAT activation and ROS production and increases the survival rate of mice after LPS challenge[J]. Int Immunopharmacol, 2017, 48:159-168.
[39] Yu Q, Zeng KW, Ma XL, et al. Ginsenoside Rk1 suppresses pro-inflammatory responses in lipopolysaccharide-stimulated RAW264.7 cells by inhibiting the Jak2/Stat3 pathway[J]. Chin J Nat Med, 2017, 15(10):751-757.
[40] Wang LC, Liao LX, Zhao MB, et al. Protosappanin A exerts anti-neuroinflammatory effect by inhibiting JAK2-STAT3 pathway in lipopolysaccharide-induced BV2 microglia[J]. Chin J Nat Med, 2017, 15(9):674-679.
[41] Goswami KK, Sarkar M, Ghosh S, et al. Neem leaf glycoprotein regulates function of tumor associated M2 macrophages in hypoxic tumor core:Critical role of IL-10/STAT3 signaling[J]. Mol Immunol, 2016, 80:1-10.
[42] Luo YP, Zhou H, Krueger J, et al. The role of proto-oncogene Fra-1 in remodeling the tumor microenvironment in support of breast tumor cell invasion and progression[J]. Oncogene, 2010, 29(5):662-673.

Related Articles:
1. FENG Li-Li, XU Li-Sha, GUO Meng-Meng, HUANG Wei, ZHU Jia-Zhen, KONG Ling-Dong, WU Xu-Dong, XU Qiang.5, 7, 2', 4', 5'-Pentamethoxyflavanone regulates M1/M2 macrophage phenotype and protects the septic mice[J]. Chinese Journal of Natural Medicines, 2019,17(5): 363-371